Foundations Investment Advisors’s Gilead Sciences GILD Stock Holding History

Foundations Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.1M	Buy	127,441 +18,201	+17%	+$2.4M	0.17%	137
2026 Q1	$15.2M	Buy	109,240 +10,495	+11%	+$1.47M	0.19%	123
2025 Q4	$12.1M	Buy	98,745 +7,603	+8%	+$924K	0.16%	135
2025 Q3	$10.1M	Buy	91,142 +8,266	+10%	+$940K	0.15%	137
2025 Q2	$9.19M	Buy	82,876 +17,318	+26%	+$1.84M	0.15%	144
2025 Q1	$7.35M	Buy	65,558 +2,476	+4%	+$255K	0.14%	152
2024 Q4	$5.83M	Buy	63,082 +13,417	+27%	+$1.21M	0.11%	165
2024 Q3	$4.16M	Buy	49,665 +8,662	+21%	+$661K	0.09%	196
2024 Q2	$2.81M	Buy	41,003 +5,742	+16%	+$383K	0.07%	205
2024 Q1	$2.58M	Buy	35,261 +922	+3%	+$70.9K	0.07%	213
2023 Q4	$2.68M	Sell	34,339 -1,785	-5%	-$139K	0.07%	198
2023 Q3	$2.71M	Buy	36,124 +2,936	+9%	+$226K	0.08%	190
2023 Q2	$2.56M	Buy	33,188 +2,206	+7%	+$176K	0.08%	160
2023 Q1	$2.57M	Buy	30,982 +678	+2%	+$56.2K	0.09%	137
2022 Q4	$2.6M	Buy	30,304 +21,511	+245%	+$1.7M	0.1%	105
2022 Q3	$542K	Buy	+8,793	New	+$554K	0.02%	226

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Foundations Investment Advisors's GILD Position: Q2 2026 in Review

Foundations Investment Advisors increased its Gilead Sciences (GILD) stake by 17% in Q2 2026, buying an estimated $2.4M and bringing the position to 127,441 shares worth $16.1M. The position accounts for 0.17% of the portfolio, ranked #137.

Foundations Investment Advisors first reported a position in GILD in Q3 2022 and has held it in 16 quarters since. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Foundations Investment Advisors held 127,441 shares of Gilead Sciences worth $16.1M as of Q2 2026.
Foundations Investment Advisors bought 18,201 Gilead Sciences shares in Q2 2026, an estimated $2.4M.
Gilead Sciences made up 0.17% of Foundations Investment Advisors's portfolio in Q2 2026, its #137 holding.
Foundations Investment Advisors first reported a position in Gilead Sciences in Q3 2022 and has held it in 16 quarters since.
2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Foundations Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.